The Rally! Foundation through its Collaborative Pediatric Cancer Research Awards Program will fund a 2-year research grant to study Glutamine Synthetase as a therapeutic target in T-ALL! Thanks for your support!!
Collin is awarded an ALSF POST undergraduate fellowship!
Collin is one of the 2023 awardees of the Alex’s Lemonade Stand Foundation (ALSF) Pediatric Oncology Student Training (POST) program. This is an exciting opportunity for Collin to keep getting hands on training on pediatric leukemia research, way to go!!
Herranz Lab co-authored publication in Nature
The Herranz lab collaborates with the Rabinowitz Lab (Princeton) to publish an article in Nature:
Slow TCA flux and ATP production in primary solid tumours but not metastases
https://www.nature.com/articles/s41586-022-05661-6
2022 Xmas Lab Party
Thank you everyone for a really fun time! With best wishes for 2023!!
Vicky accepted to the TRTH program!
Vicky is one of the 2023 awardees of the TRTH program from ASH and EHA. This is an exciting opportunity for her, congrats Vicky!!
Oekyung Kim joins the Herranz Lab as a Research Scientist
Welcome to the lab, Oekyung!
The Herranz lab collaborates with the Jacinto Lab (Rutgers) to publish an article in Nature Communications:
Dietary glucosamine overcomes the defects in αβ-T cell ontogeny caused by the loss of de novo hexosamine biosynthesis
https://www.nature.com/articles/s41467-022-35014-w
The Herranz Lab welcomes Amartya Singh, Chris Thai and Byron Avihai!!
We are sad to see Hossein Khiabanian leave Rutgers, but we are excited to welcome some of his previous trainees in our own lab.
Amartya Singh (postdoc), Chris Thai (PhD candidate) and Byron Avihai (MDPhD candidate) will continue their studies in our lab, welcome to all of you!!
The Herranz Lab publishes in Blood Cancer Discovery!!
Very happy to share our identification of a novel NOTCH1-SIRT1-KAT7 axis in T-ALL!
Thanks to everyone involved in this story!!
Herranz Lab publishes a comment feature in Blood
Drs. da Silva-Diz and Herranz publish comment in Blood:
Forever young: Sphk2 in HSCs, when less is more
